GMS was presented as Best Practice at the ICPerMed Conference in Berlin
Publicerat 2018-12-04 13:42. Uppdaterat 2018-12-04 14:12
The first ICPerMed Conference, 'Personalised Medicine in Action' took place on 20-21 November 2018 in Berlin, Germany. The aim of the conference was to present best practice examples of successful implementation of personalised medicine approaches in Europe and beyond.
Genomic Medicine Sweden (GMS) was selected as one of the Best Practice Examples of Personalised Medicine Research & Implementation - From Basic Research to the Patient; Acceleration of Implementation of Personalised Medicine for Rare Diseases and Cancer.
Both Professor Richard Rosenquist Brandell, Head of GMS, Sweden and Professor Anna Wedell, was engaged as speakers at the conference.
The International Consortium for Personalised Medicine, ICPerMed, was initiated during several workshops organised by the European Commission throughout 2016. The basis for this was the previous project, PerMed, that was funded from 2013-2015 by the European Union's 7th Framework Programme and brought together many organisations active in the area. PerMed already made clear that real progress in personalised medicine can only be achieved when research and implementation efforts are covering the entire value chain. This was documented in a Strategic Research and Innovation Agenda describing challenges and giving recommendations for advancing this field.